Pharmaceutical and alimentary compositions containing Acetobacter xylinum as the active ingredient for the treatment of gastroenteral dysmicrobisms, gastroenteral acute and chronic infections and impairments of the gastroenteral functionality.

The present invention relates to compositions comprising essentially amorphous cellulose nanofibrils, at least one additive chosen from carboxycellulose with a degree of substitution of more than 0.95, a natural polysaccharide, a polyol, and optionally at least one co-additive, the content of additive and of optional co-additive being less than or equal to 30% by weight relative to the weight of nanofibrils and of additive and of optional co-additive. Similarly, a subject of the invention is a process for preparing such compositions, which consists in adding the additive and the optional co-additive to a suspension of essentially amorphous nanofibrils, and then in drying the suspension thus supplemented. The compositions obtained are readily redispersable and conserve their initial rheological properties.

The invention concerns the use, in dry form, of a combination of substantially amorphous microfibrils with a crystallinity index not more than 50%, with at least a polyhydroxylated compound, as additive for food formulations, the content of this combination being more than 0% and less than 20% by weight relative to the total weight of the food formulation.

The present invention relates to foodstuffs which are prepared by adding konjak paste having a pH value of 9.0 to 10.3 and relates to the process for preparing the same.

The present invention relates to foodstuffs which are prepared by adding konjak paste having a pH value of 9.0 to 10.3 and relates to the process for preparing the same.